edap tms - EDAP

EDAP

Close Chg Chg %
3.53 -0.18 -5.10%

Closed Market

3.35

-0.18 (5.10%)

Volume: 51.03K

Last Updated:

Apr 2, 2026, 4:00 PM EDT

Company Overview: edap tms - EDAP

EDAP Key Data

Open

$3.41

Day Range

3.19 - 3.50

52 Week Range

1.21 - 5.05

Market Cap

$127.06M

Shares Outstanding

37.48M

Public Float

37.41M

Beta

-0.08

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$0.78

Yield

0.00%

Dividend

N/A

EX-DIVIDEND DATE

SHORT INTEREST

N/A

AVERAGE VOLUME

40.11K

 

EDAP Performance

1 Week
 
-9.12%
 
1 Month
 
-17.92%
 
3 Months
 
-0.29%
 
1 Year
 
110.56%
 
5 Years
 
-60.44%
 

EDAP Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 3
Full Ratings ➔

About edap tms - EDAP

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

EDAP At a Glance

EDAP TMS SA
Vaulx-en-Velin, Auvergne-Rhone-Alpes 69120
Phone 33-4-72-15-31-50 Revenue 70.75M
Industry Medical Specialties Net Income -29,336,493.06
Sector Health Technology 2025 Sales Growth 2.008%
Fiscal Year-end 12 / 2026 Employees 289
View SEC Filings

EDAP Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.741
Price to Book Ratio 6.352
Price to Cash Flow Ratio N/A
Enterprise Value to EBITDA -5.987
Enterprise Value to Sales 1.843
Total Debt to Enterprise Value 0.212

EDAP Efficiency

Revenue/Employee 244,793.166
Income Per Employee -101,510.357
Receivables Turnover 3.133
Total Asset Turnover 0.842

EDAP Liquidity

Current Ratio 1.539
Quick Ratio 1.194
Cash Ratio 0.551

EDAP Profitability

Gross Margin 42.538
Operating Margin -35.633
Pretax Margin -41.367
Net Margin -41.468
Return on Assets -34.90
Return on Equity -95.00
Return on Total Capital -62.29
Return on Invested Capital -69.567

EDAP Capital Structure

Total Debt to Total Equity 142.605
Total Debt to Total Capital 58.781
Total Debt to Total Assets 35.044
Long-Term Debt to Equity 94.437
Long-Term Debt to Total Capital 38.926
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Edap Tms - EDAP

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
57.92M 65.32M 69.35M 70.75M
Sales Growth
+11.20% +12.79% +6.17% +2.01%
Cost of Goods Sold (COGS) incl D&A
32.49M 38.93M 40.63M 40.65M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.72M 2.08M 2.80M 3.43M
Depreciation
1.57M 1.89M 2.57M 3.12M
Amortization of Intangibles
148.19K 189.20K 237.97K 304.94K
COGS Growth
+7.20% +19.82% +4.35% +0.06%
Gross Income
25.43M 26.39M 28.73M 30.09M
Gross Income Growth
+16.77% +3.80% +8.84% +4.76%
Gross Profit Margin
+43.90% +40.40% +41.42% +42.54%
2022 2023 2024 2025 5-year trend
SG&A Expense
30.77M 48.49M 51.68M 55.30M
Research & Development
6.04M 8.21M 9.10M 10.13M
Other SG&A
24.73M 40.28M 42.58M 45.17M
SGA Growth
+21.72% +57.58% +6.57% +7.01%
Other Operating Expense
- - - -
-
Unusual Expense
- - - 2.58M
-
EBIT after Unusual Expense
(5.35M) (22.10M) (22.95M) (27.79M)
Non Operating Income/Expense
2.71M (288.66K) 2.46M (684.11K)
Non-Operating Interest Income
424.59K 1.42M 861.03K 252.78K
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
176.56K 250.82K 255.28K 791.44K
Interest Expense Growth
+187.27% +42.06% +1.78% +210.03%
Gross Interest Expense
176.56K 250.82K 255.28K 791.44K
Interest Capitalized
- - - -
-
Pretax Income
(2.81M) (22.64M) (20.75M) (29.27M)
Pretax Income Growth
-962.42% -704.81% +8.34% -41.01%
Pretax Margin
-4.86% -34.66% -29.93% -41.37%
Income Tax
269.05K 252.73K (183.02K) 71.22K
Income Tax - Current - Domestic
509.72K 84.08K 49.55K 45.14K
Income Tax - Current - Foreign
263.79K 576.23K 384.00K 559.73K
Income Tax - Deferred - Domestic
8.41K (3.24K) (5.41K) (2.01K)
Income Tax - Deferred - Foreign
97.74K 40.00K (115.74K) (163.50K)
Income Tax Credits
610.62K 444.34K 495.41K 368.14K
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
(3.08M) (22.90M) (20.57M) (29.34M)
Minority Interest Expense
- - - -
-
Net Income
(3.08M) (22.90M) (20.57M) (29.34M)
Net Income Growth
-472.56% -642.76% +10.15% -42.61%
Net Margin Growth
-5.32% -35.05% -29.66% -41.47%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
(3.08M) (22.90M) (20.57M) (29.34M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(3.08M) (22.90M) (20.57M) (29.34M)
EPS (Basic)
-0.0896 -0.6189 -0.5517 -0.7835
EPS (Basic) Growth
-447.29% -590.74% +10.86% -42.02%
Basic Shares Outstanding
34.39M 37.00M 37.29M 37.44M
EPS (Diluted)
-0.0896 -0.6189 -0.5517 -0.7835
EPS (Diluted) Growth
-451.37% -590.74% +10.86% -42.02%
Diluted Shares Outstanding
34.39M 37.00M 37.29M 37.44M
EBITDA
(3.63M) (20.02M) (20.15M) (21.78M)
EBITDA Growth
-193.16% -451.89% -0.64% -8.10%
EBITDA Margin
-6.26% -30.65% -29.06% -30.79%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 5.881
Number of Ratings 3 Current Quarters Estimate -0.166
FY Report Date 06 / 2026 Current Year's Estimate -0.646
Last Quarter’s Earnings -0.188 Median PE on CY Estimate N/A
Year Ago Earnings -0.69 Next Fiscal Year Estimate -0.498
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 2 2 2 2
Mean Estimate -0.17 -0.16 -0.65 -0.50
High Estimates -0.14 -0.13 -0.57 -0.49
Low Estimate -0.19 -0.19 -0.72 -0.50
Coefficient of Variance -20.58 -28.67 -15.71 -0.94

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 1 1 1
OVERWEIGHT 0 0 0
HOLD 2 2 2
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Edap Tms in the News